Portal de Periódicos da CAPES

Mortality and renal outcomes of patients with severe COVID-19 treated in a provisional intensive care unit

2020; Elsevier BV; Volume: 62; Linguagem: Inglês

10.1016/j.jcrc.2020.12.012

1557-8615

Erin Hittesdorf, Oliver Panzer, David Wang, Jacob S. Stevens, Jonathan Hastie, Desmond Jordan, Nina Yoh, Katherine A. Eiseman, Katerina Elisman, Gebhard Wagener,

Intensive Care Unit Cognitive Disorders

COVID-19 has created an enormous health crisis and this spring New York City had a severe outbreak that pushed health and critical care resources to the limit. A lack of adequate space for mechanically ventilated patients induced our hospital to convert operating rooms into critical care areas (OR-ICU). A large number of COVID-19 will develop acute kidney injury that requires renal replacement therapy (RRT). We included 116 patients with COVID-19 who required mechanical ventilation and were cared for in our OR-ICU. At 90 days and at discharge 35 patients died (30.2%). RRT was required by 45 of the 116 patients (38.8%) and 18 of these 45 patients (40%) compared to 17 with no RRT (23.9%, ns) died during hospitalization and after 90 days. Only two of the 27 patients who required RRT and survived required RRT at discharge and 90 days. When defining renal recovery as a discharge serum creatinine within 150% of baseline, 68 of 78 survivors showed renal recovery (87.2%). Survival was similar to previous reports of patients with severe COVID-19 for patients cared for in provisional ICUs compared to standard ICUs. Most patients with severe COVID-19 and AKI are likely to recover full renal function.